The hOGG1 (8-oxoguanine-DNA glycosylase) gene may contribute to further understanding of the relation between oxidative DNA damage and carcinogenesis. A real-time PCR technique was used to determine mRNA levels in peripheral blood cells to assess the possibility of using hOGG1 mRNA as a biomarker in epidemiological studies. To evaluate the intra- and interindividual variation of hOGG1 mRNA levels in peripheral blood cells, we measured them in five healthy nonsmokers three times over a 1-year period. The β-actin mRNA level in each subject was set equal to 100, and the levels of hOGG1 mRNA were found to range from 1.6–17.6. The intraindividual variation range was 1.8–6.4. Although the difference in the mRNA levels between the sampling dates was not significant (P = 0.73), a significant difference in mRNA levels was found between the subjects(P < 0.01). The subjects seemed to fall into groups according to their individual levels. This preliminary study may provide initial information on the hOGG1 mRNA level of peripheral blood cells as a biomarker in epidemiological studies on oxygen radicals, oxygen radical-related agents, and cancer.

Reactive oxygen species are produced in response to environmental chemical and radiation exposure and are even produced in some basic metabolic pathways. They can interact with DNA to produce a variety of damage. Oxidation at the C8 position of a guanine,8-oxoG,3is a representative oxidative DNA damage (1), and it is highly mutagenic because of its potential to mispair with adenine during replication. Loss of the 8-oxoG repair enzyme in yeast can lead to increased levels of mutagenesis, suggesting that defects in the human repair system are important in carcinogenesis (2). The hOGG1 (8-oxoG-DNA glycosylase) gene has been found to be an excision repair gene for this oxidized guanine (3, 4, 5, 6, 7, 8),and it may contribute to further understanding of the relation between oxidative DNA damage and carcinogenesis.

Some previous studies have suggested that mRNA expression of DNA repair genes in peripheral blood cells can provide information on susceptibility to cancer (9, 10, 11), and we suspected that expression of hOGG1 mRNA might provide similar information. We also speculated that the mRNA level of peripheral blood cells might serve as a marker of exposure to reactive oxygen radicals or radical-generating factors because some reports have shown that repair activity might be induced by exposure to such factors (12, 13, 14).

Quantitative determination of mRNA itself involves technical difficulties; however, a real-time PCR has recently been developed (15, 16) and has yielded reproducible results. The objective of this preliminary study was to use the real-time PCR technique to evaluate the intra- and interindividual variation of hOGG1 mRNA levels in the peripheral blood cells of nonsmokers over a 1-year period and to assess whether its levels could serve as a biomarker in epidemiological studies.

Subjects and Sample Collection.

Five healthy volunteers (age range, 35–43 years) participated in the study. All participants were nonsmokers, and none of them had a history of occupational chemical exposure. Their peripheral blood samples were collected three times: (a) at baseline; (b) 1 week later; and (c) after approximately 1 year. All participants gave informed consent.

Peripheral venous blood was collected into a Na2EDTA tube. The buffy coat was immediately fractionated from approximately 3 ml of blood by centrifugation. WBCs were obtained from the buffy coat by osmotic hemolysis using a 0.2%NaCl solution.

RNA Extraction.

Total RNA was isolated from WBCs by using a commercial RNA isolation reagent according to the manufacturer’s instructions (Trizol reagent;Life Technologies, Inc., Rockville, MD).

Reverse Transcription.

The prepared RNA was reverse transcribed to synthesize cDNA using avian myeloblastosis virus reverse transcriptase XL according to the manufacturer’s instructions (Takara Biochemicals, Osaka, Japan).

Real-Time PCR.

We used real-time TaqMan technology with an ABI Prism 7700 Sequence Detector (PE Biosystems, Foster City, CA) to quantitatively compare the mRNA levels. The principle of the technology has been described elsewhere (15, 16). The amount of template cDNA was expressed by a threshold cycle (CT) that was determined by the amplification curve (exponential phase) and a threshold level of PCR product detection. One CTwas equal to a 2-fold difference in initial template.

hOGG1 mRNA levels were compared between subjects by a comparative CT method with separate tubes, as described elsewhere (User Bulletin 2; PE Biosystems). Briefly, the individual level of initial target cDNA was expressed as the difference in CT between the target and an endogenous control (ΔCT). The relative amount of target in a subject, normalized to an endogenous control, was finally given by 2ΔCT.

Specific primers and a specific TaqMan probe were designed between exon 2 and exon 3 according to a published sequence (GenBank AB000410):(a) forward primer, AATTCCAAGGTGTGCGACTG; (b)reverse primer, CGATGTTGTTGTTGGAGGAAC; and (c) probe,5′-FAM-CGACAAGACCCCATCGAATGCCTTTTC-TAMRA-3′. The PCR reaction was carried out with TaqMan Universal PCR Master Mix according to the manufacturer’s instructions (PE Biosystems). We used theβ-actin gene as the endogenous control gene, and the PCR reaction forβ-actin was carried out according to the manufacturer’s instructions(predeveloped TaqMan assay reagent, human β-actin; PE Biosystems).

All measurements were performed in duplicate experiments on one experiment day. The average difference in CTbetween duplicate analyses was 0.4 CT (about 1.3 times the difference in initial template).

Determination of Endogenous Control Genes.

Appropriate endogenous control genes were determined before measurement of hOGG1 mRNA levels. Five healthy volunteers (age range,26–40 years), including one smoker, voluntarily donated RNA samples,and their samples were extracted by the method described above. DNase-treated RNA was reverse transcribed to synthesize cDNA by using SUPERSCRIPT II reverse transcriptase according to the manufacturer’s instructions (Life Technologies, Inc.).

We examined interindividual differences in the candidate genes by using TaqMan human endogenous control plate (PE Biosystems). The candidate genes included 18S rRNA, acidic ribosomal protein, β-actin,cyclophilin, GAPDH, phosphoglycerokinase,β 2-microglobulin, β-glucuronidase,hypoxanthine ribosyl transferase, transcription factor IID TATA-binding protein, and transferrin receptor. With the exception of 18S rRNA, the primers and the probes of the candidate genes recognized only cDNA. The amount of cDNA sample for the PCR reaction was adjusted between subjects with a spectrophotometer. The PCR conditions were set according to manufacturer’s instructions. All measurements were performed in duplicate experiments.

Fig. 1 shows the results of quantitative comparison of 8 genes in the 11 candidates examined because mRNA levels of 3 genes,hypoxanthine ribosyl transferase, transcription factor IID TATA-binding protein, and transferrin receptor, were very low or undetectable in the peripheral blood cells of most of these subjects. The 18S rRNA showed the smallest interindividual differences among the genes studied. The amounts of GAPDH, β-actin, phosphoglycerokinase, andβ-glucuronidase varied in a relatively small range (less than twice the difference) compared with the others. The order of the relative amounts of these genes in peripheral blood cells was as follows: 18S rRNA > β-actin > GAPDH >phosphoglycerokinase > β-glucuronidase (approximately 1000:1:0.1:0.025:0.002).

Fig. 2 shows the intra- and interindividual variation of hOGG1 mRNA levels in the peripheral blood cells of the subjects over a 1-year period. The levels of hOGG1 mRNA ranged from 1.6 to 17.6(hOGG1/β-actin × 100). The intraindividual variation ranged from 1.8 to 6.4(hOGG1/β-actin × 100). Although the differences in the mRNA levels between the sampling dates were not significant (P = 0.73, ANOVA), we observed a significant difference in the mRNA levels between the subjects(P < 0.01, ANOVA).

We evaluated the intra- and interindividual variation of hOGG1 mRNA levels in peripheral blood cells by using the real-time PCR technique. The results of this preliminary study showed that the interindividual variation may be larger than the intraindividual variation.

The analytical method used in this study, real-time PCR, provided a more accurate estimation than previous methods, including competitive reverse transcription-PCR using gel electrophoresis. We examined the exponential phase of the PCR reaction directly and compared the amount of initial template cDNA between subjects. Some housekeeping genes have been used for quantitative assessment of mRNA expression as endogenous controls to adjust the total amount of RNA between samples because such genes are thought to be expressed at the same level in all subjects. Expression of a target gene has been compared to that of an endogenous control gene by using photographs of a gel electrophoresis. However, it is well known that such methods yield large errors in determinations of the expression of the target genes. Moreover, some recent reports have suggested that the expression of such genes in some tissues may vary among study subjects (17). The real-time quantitative PCR technique can provide a precise level of target gene expression;however, more appropriate internal controls need to be prepared.

First, we determined appropriate endogenous control genes in peripheral blood cells for quantitative analysis of mRNA. The 18S rRNA seemed to be the best endogenous control gene for quantitative gene expression studies using peripheral blood cells. However, we suspected that normalization using 18S rRNA might generate large errors when target genes are expressed at a relatively low levels because the 18S rRNA expression level is very high. The GAPDH, β-actin,phosphoglycerokinase, and β-glucuronidase genes seemed to be acceptable, although we should assume an error of approximately 2-fold. We used β-actin as an endogenous control in this study.

Wei et al.(9, 10, 11) suggested that mRNA expression of DNA repair genes in peripheral blood cells could provide information on susceptibility to cancer. They observed that low expression of some mismatch repair genes (hMLH1 and hGTBP/hMSH6) was associated with an increased risk of head and neck cancer. The level of hOGG1 mRNA in peripheral blood cells may also provide information on susceptibility to cancer.

Whether the interindividual variation of a marker is greater than the intraindividual variation is indispensable information for a biomarker in epidemiological studies. Our observation showed that the interindividual variation of hOGG1 mRNA was larger than the intraindividual variation. The subjects seemed to fall into groups according to their individual levels of hOGG1 mRNA;however, the sample size in this preliminary study was limited, and thus we cannot conclude that the level is peculiar to each subject.

We can speculate that the interindividual variation of hOGG1mRNA is genetically determined or epigenetically influenced by endogenous and/or environmental exposure. One possibility is that hOGG1 mRNA is induced by exposure to reactive oxygen radicals or radical-generating factors. Increased 8-oxoG repair activity has been demonstrated in smokers’ leukocytes (12) and in rats exposed to asbestos (13). Moreover, Tsurudome et al.(14) demonstrated increased expression of hOGG1 in rats exposed to diesel exhaust particles. Some previous studies have suggested that quantitative assessment of mRNA expression in peripheral blood cells can provide information on exposure to environmental carcinogens. The target mRNA has been studied mainly with regard to metabolic enzymes and related cellular receptors (18, 19, 20). In this study, we assessed hOGG1 mRNA levels only in nonsmokers. Additional studies are needed to determine the levels in subjects exposed to chemicals that generate reactive oxygen radicals.

We used peripheral WBCs because we have often stored WBCs in the form of buffy coat in epidemiological studies. Peripheral blood cells are a surrogate tissue for target organs, which are not easily obtained in epidemiological studies. Quantitative comparisons between hOGG1 mRNA levels in peripheral blood cells and in target organs are needed. However, the level in peripheral blood cells was adequate for comparisons between subjects, and it promises to provide information for epidemiological studies.

In conclusion, we use the real-time PCR technique to estimate intra-and interindividual variations of hOGG1 mRNA levels in peripheral blood cells over a 1-year period and found that the interindividual variation was larger than the intraindividual variation. Although more study is needed to validate these variations,and biological validation of this assay appears to be quite difficult at the present time, this preliminary study appears to provide initial information on the hOGG1 mRNA levels of peripheral blood cells as a biomarker for epidemiological studies on oxygen radicals,oxygen radical-related agents, and cancer.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

        
1

Supported in part by a Grant-in-Aid for the Second Term Comprehensive 10-Year Strategy for Cancer Control and for Cancer Research of the Ministry of Health and Welfare of Japan and a Grant-in-Aid for Scientific Research from the Ministry of Education,Science, Sports and Culture of Japan. T. H. is an Awardee of a Research Fellowship from the Foundation for Promotion of Cancer Research in Japan.

                
3

The abbreviations used are: 8-oxoG,8-oxoguanine; GAPDH, glyceraldehyde-3-phosphate dehydrogenase;CT, threshold cycle.

Fig. 1.

Relative mRNA levels of candidate genes to determine endogenous control genes in peripheral blood cells. Eleven genes were examined in five subjects as described in the text. Eight of 11 genes are shown in this figure because mRNA levels of three genes,hypoxanthine ribosyl transferase, transcription factor IID TATA binding protein, and transferrin receptor, were very low or undetectable. A mRNA level (CT) of one subject is set at 0, andΔCT shows the difference between this subject and the four other subjects. 18S, 18S rRNA; PO,acidic ribosomal protein; BA, β-actin; CYC, cyclophilin; PGK,phosphoglycerokinase; β2m2-microglobulin; GUS,β-glucuronidase.

Fig. 1.

Relative mRNA levels of candidate genes to determine endogenous control genes in peripheral blood cells. Eleven genes were examined in five subjects as described in the text. Eight of 11 genes are shown in this figure because mRNA levels of three genes,hypoxanthine ribosyl transferase, transcription factor IID TATA binding protein, and transferrin receptor, were very low or undetectable. A mRNA level (CT) of one subject is set at 0, andΔCT shows the difference between this subject and the four other subjects. 18S, 18S rRNA; PO,acidic ribosomal protein; BA, β-actin; CYC, cyclophilin; PGK,phosphoglycerokinase; β2m2-microglobulin; GUS,β-glucuronidase.

Close modal
Fig. 2.

Intra- and interindividual variations of hOGG1 mRNA levels in peripheral blood cells of the subjects over a 1-year period. The Y axis shows the relative level normalized toβ-actin, with the level of β-actin mRNA in each subject set at 100.

Fig. 2.

Intra- and interindividual variations of hOGG1 mRNA levels in peripheral blood cells of the subjects over a 1-year period. The Y axis shows the relative level normalized toβ-actin, with the level of β-actin mRNA in each subject set at 100.

Close modal

We are grateful to Osamu Sakatsume for technical advice and for the design of the primers and probe used in this study.

1
Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis.
Mutat. Res.
,
387
:
147
-163,  
1997
.
2
Cunningham R. P. DNA repair: caretakers of the genome?.
Curr. Biol.
,
7
:
R576
-R579,  
1997
.
3
Lu R., Nash H. M., Verdine G. L. A mammalian DNA repair enzyme that excises oxidatively damaged guanines maps to a locus frequently lost in lung cancer.
Curr. Biol.
,
7
:
397
-407,  
1997
.
4
Arai K., Morishita K., Shinmura K., Kohno T., Kim S. R., Nohmi T., Taniwaki M., Ohwada S., Yokota J. Cloning of a human homolog of the yeast OGG1 gene that is involved in the repair of oxidative DNA damage.
Oncogene
,
14
:
2857
-2861,  
1997
.
5
Aburatani H., Hippo Y., Ishida T., Takashima R., Matsuba C., Kodama T., Takao M., Yasui A., Yamamoto K., Asano M. Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutM homologue.
Cancer Res.
,
57
:
2151
-2156,  
1997
.
6
Rosenquist T. A., Zharkov D. O., Grollman A. P. Cloning and characterization of a mammalian 8-oxoguanine DNA glycosylase.
Proc. Natl. Acad. Sci. USA
,
94
:
7429
-7434,  
1997
.
7
Radicella J. P., Dherin C., Desmaze C., Fox M. S., Boiteux S. Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae.
Proc. Natl. Acad. Sci. USA
,
94
:
8010
-8015,  
1997
.
8
Roldan-Arjona T., Wei Y. F., Carter K. C., Klungland A., Anselmino C., Wang R. P., Augustus M., Lindahl T. Molecular cloning and functional expression of a human cDNA encoding the antimutator enzyme 8-hydroxyguanine-DNA glycosylase.
Proc. Natl. Acad. Sci. USA
,
94
:
8016
-8020,  
1997
.
9
Wei Q., Xu X., Cheng L., Legerski R. J., Ali-Osman F. Simultaneous amplification of four DNA repair genes and β-actin in human lymphocytes by multiplex reverse transcriptase-PCR.
Cancer Res.
,
55
:
5025
-5029,  
1995
.
10
Wei Q., Bondy M. L., Mao L., Guan Y., Cheng L., Cunningham J., Fan Y., Bruner J. M., Yung W. K. A., Levin V. A., Kyritsis A. P. Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas.
Cancer Res.
,
57
:
1673
-1677,  
1997
.
11
Wei Q., Eicher S. A., Guan Y., Cheng L., Xu J., Young L. N., Saunders K. C., Jiang H., Hong W. K., Spitz M. R., Strom S. S. Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer.
Cancer Epidemiol. Biomark. Prev.
,
7
:
309
-314,  
1998
.
12
Asami S., Hirano T., Yamaguchi R., Tomioka Y., Itoh H., Kasai H. Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking.
Cancer Res.
,
56
:
2546
-2549,  
1996
.
13
Yamaguchi R., Hirano T., Ootsuyama Y., Asami S., Tsurudome Y., Fukada S., Yamato H., Tsuda T., Tanaka I., Kasai H. Increased 8-hydroxyguanine in DNA and its repair activity in hamster and rat lung after intratracheal instillation of crocidolite asbestos.
Jpn. J. Cancer Res.
,
90
:
505
-509,  
1999
.
14
Tsurudome Y., Hirano T., Yamato H., Tanaka I., Sagai M., Hirano H., Nagata N., Itoh H., Kasai H. Changes in levels of 8-hydroxyguanine in DNA, its repair and OGG1 mRNA in rat lungs after intratracheal administration of diesel exhaust particles.
Carcinogenesis (Lond.)
,
20
:
1573
-1576,  
1999
.
15
Gibson U. E., Heid C. A., Williams P. M. A novel method for real time quantitative RT-PCR.
Genome Res.
,
6
:
995
-1001,  
1996
.
16
Heid C. A., Stevens J., Livak K. J., Williams P. M. Real-time quantitative PCR.
Genome Res.
,
6
:
986
-994,  
1996
.
17
Piechaczyk M., Blanchard J. M., Marty L., Dani C., Panabieres F., El Sabouty S., Fort P., Jeanteur P. Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues.
Nucleic Acids Res.
,
12
:
6951
-6963,  
1984
.
18
Cosma G. N., Toniolo P., Currie D., Pasternack B. S., Garte S. J. Expression of the CYP1A1 gene in peripheral lymphocytes as a marker of exposure to creosote in railroad workers.
Cancer Epidemiol. Biomark. Prev.
,
1
:
137
-142,  
1992
.
19
van den Heuvel J. P., Clark G. C., Thompson C. L., McCoy Z., Miller C. R., Lucier G. W., Bell D. A. CYP1A1 mRNA levels as a human exposure biomarker: use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes.
Carcinogenesis (Lond.)
,
14
:
2003
-2006,  
1993
.
20
Hayashi S., Watanabe J., Nakachi K., Eguchi H., Gotoh O., Kawajiri K. Interindividual difference in expression of human Ah receptor and related P450 genes.
Carcinogenesis (Lond.)
,
15
:
801
-806,  
1994
.